ID: ALA4563705

Max Phase: Preclinical

Molecular Formula: C32H38F3N7O8S

Molecular Weight: 623.74

Molecule Type: Unknown

Representations

Canonical SMILES:  COc1ccccc1CC(=O)Nc1c[nH]nc1C(=O)NC1CCN(S(=O)(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)CC1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C30H37N7O6S.C2HF3O2/c1-36(2)15-7-12-27(38)32-23-9-6-10-24(19-23)44(41,42)37-16-13-22(14-17-37)33-30(40)29-25(20-31-35-29)34-28(39)18-21-8-4-5-11-26(21)43-3;3-2(4,5)1(6)7/h4-12,19-20,22H,13-18H2,1-3H3,(H,31,35)(H,32,38)(H,33,40)(H,34,39);(H,6,7)/b12-7+;

Standard InChI Key:  HWYLKHCBJNVQSZ-RRAJOLSVSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 623.74

Molecular Weight (Monoisotopic): 623.2526

AlogP: 2.24

#Rotatable Bonds: 12

Polar Surface Area: 165.83

Molecular Species: BASE

HBA: 8

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 13

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 10.84

CX Basic pKa: 8.80

CX LogP: 1.97

CX LogD: 0.55

Aromatic Rings: 3

Heavy Atoms: 44

QED Weighted: 0.22

Np Likeness Score: -1.70

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source

Source(1):

• Scientific Literature